As of 2025-05-19, the Intrinsic Value of Innoviva Inc (INVA) is 55.49 USD. This INVA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 18.58 USD, the upside of Innoviva Inc is 198.60%.
The range of the Intrinsic Value is 45.13 - 72.26 USD
Based on its market price of 18.58 USD and our intrinsic valuation, Innoviva Inc (INVA) is undervalued by 198.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 45.13 - 72.26 | 55.49 | 198.6% |
| DCF (Growth 10y) | 59.62 - 93.89 | 72.75 | 291.6% |
| DCF (EBITDA 5y) | 24.35 - 28.77 | 26.44 | 42.3% |
| DCF (EBITDA 10y) | 37.66 - 44.95 | 41.06 | 121.0% |
| Fair Value | -4.76 - -4.76 | -4.76 | -125.60% |
| P/E | (10.69) - 11.94 | (1.54) | -108.3% |
| EV/EBITDA | 15.63 - 21.79 | 18.52 | -0.3% |
| EPV | 35.38 - 46.00 | 40.69 | 119.0% |
| DDM - Stable | (8.04) - (16.61) | (12.33) | -166.3% |
| DDM - Multi | 6.33 - 10.49 | 7.92 | -57.4% |
| Market Cap (mil) | 1,166.27 |
| Beta | 0.35 |
| Outstanding shares (mil) | 62.77 |
| Enterprise Value (mil) | 1,296.06 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.72% |
| Cost of Debt | 4.25% |
| WACC | 6.54% |